Patents by Inventor Raed I Felimban

Raed I Felimban has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Icariin nano-pharmaceutical formulation
    Patent number: 11559495
    Abstract: A nano-pharmaceutical formulation, comprising zein nanoparticles, icariin (ICA) or a pharmaceutically acceptable salt thereof encapsulated within the zein nanoparticles, at least one solubilizer, wherein the at least one solubilizer comprises D-a-Tocopherol polyethylene glycol 1000 succinate (TPGS), and one or more pharmaceutical penetration enhancers is provided. Methods of enhancing libido by administering a composition as described herein is also provided.
    Type: Grant
    Filed: March 7, 2022
    Date of Patent: January 24, 2023
    Assignee: KING ABDULAZIZ UNIVERSITY
    Inventors: Hani Z. Asfour, Nabil A. Alhakamy, Raed I. Felimban, Osama A. A. Ahmed, Waleed Y. Rizg, Usama A. Fahmy, Ashraf B. Abdel-Naim
  • Methods for treating metabolic disorder
    Patent number: 11298321
    Abstract: Provided are a self-nanoemulsifying 3D printer ink composition and a method of using such composition to manufacture a 3D-printed tablet having compartmentalized active pharmaceutical ingredients. In particular, the 3D-printed tablet composition includes glimepiride and/or rosuvastatin in a curcuma oil based self-nanoemulsifying drug delivery system (SNEDDS). The disclosure also provides a method of treating a metabolic disorder or disease by administering a therapeutically effective amount of the 3D-printed tablet to a subject in need thereof.
    Type: Grant
    Filed: October 25, 2021
    Date of Patent: April 12, 2022
    Assignee: KING ABDULAZIZ UNIVERSITY
    Inventors: Khalid M. El-Say, Tarek A Ahmed, Raed I. Felimban, Hossam H. Tayeb, Waleed Y Rizg, Fuad H. AlNadwi, Abdelsattar M. Omar
  • Ketoconazole ophthalmic preparations containing trans-ethosomal drug nanoparticles
    Patent number: 11285148
    Abstract: An ophthalmic formulation comprising transethosomes is provided. The transethosomes include a phospholipid, an edge activator, ethanol, and ketoconazole, wherein a surface of the transethosome is modified with a cationic charge inducing agent. The transethosomes may be incorporated into in situ gelling or hydrogel compositions. The formulations are useful for the sustained delivery of ketoconazole to the posterior eye segment of a subject.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: March 29, 2022
    Assignee: KING ABDULAZIZ UNIVERSITY
    Inventors: Tarek A. Ahmed, Maram M. Alzahrani, Nabil A. Alhakamy, Raed I. Felimban
  • Self-nanoemulsifying 3D-printed tablet composition and method of use thereof
    Patent number: 11253481
    Abstract: Provided are a self-nanoemulsifying 3D printer ink composition and a method of using such composition to manufacture a 3D-printed tablet having compartmentalized active pharmaceutical ingredients. In particular, the 3D-printed tablet composition includes glimepiride and/or rosuvastatin in a curcuma oil based self-nanoemulsifying drug delivery system (SNEDDS).
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: February 22, 2022
    Assignee: KING ABDULAZIZ UNIVERSITY
    Inventors: Tarek A. Ahmed, Raed I Felimban, Hossam H. Tayeb, Khalid M. El-Say, Waleed Y Rizg, Fuad H. Alnadwi